VanEck Associates’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Buy
202,676
+6,270
+3% +$47.2K ﹤0.01% 1057
2025
Q4
$1.41M Buy
196,406
+104,394
+113% +$825K ﹤0.01% 1042
2025
Q3
$983K Sell
92,012
-15,439
-14% -$152K ﹤0.01% 1088
2025
Q2
$1.04M Sell
107,451
-635,968
-86% -$6.56M ﹤0.01% 1045
2025
Q1
$11.1M Buy
743,419
+213,937
+40% +$3.29M 0.01% 451
2024
Q4
$7.9M Buy
529,482
+252,750
+91% +$4.12M 0.01% 534
2024
Q3
$4.76M Buy
276,732
+67,451
+32% +$1.4M 0.01% 663
2024
Q2
$4.33M Buy
209,281
+37,371
+22% +$743K 0.01% 629
2024
Q1
$3.23M Sell
171,910
-73,681
-30% -$1.26M ﹤0.01% 724
2023
Q4
$3.54M Sell
245,591
-57,588
-19% -$783K 0.01% 638
2023
Q3
$5.26M Sell
303,179
-91,614
-23% -$1.91M 0.01% 490
2023
Q2
$8.22M Buy
394,793
+130,590
+49% +$2.84M 0.02% 385
2023
Q1
$6.21M Sell
264,203
-192,039
-42% -$5.16M 0.01% 439
2022
Q4
$12.7M Buy
456,242
+42,464
+10% +$1.09M 0.03% 303
2022
Q3
$9.68M Sell
413,778
-195,486
-32% -$5.9M 0.03% 314
2022
Q2
$20.6M Buy
609,264
+281,032
+86% +$9.84M 0.05% 239
2022
Q1
$11.5M Sell
328,232
-9,306
-3% -$318K 0.02% 345
2021
Q4
$10.3M Buy
337,538
+41,705
+14% +$1.36M 0.02% 370
2021
Q3
$9.7M Buy
295,833
+106,368
+56% +$3.4M 0.02% 346
2021
Q2
$5.73M Buy
+189,465
New +$6.24M 0.01% 442

Other funds holding OGN